CD200R1 and neoplasm: Furthermore, CD200R is reportedly overexpressed and co-expressed with multiple immune checkpoints, including PD-1, CTLA-4, and TIM-3, in tumor-infiltrating T cells in NSCLC tumor tissues [130].